Viridian Therapeutics Receives FDA Approval for Lumvoa for the Treatment of Thyroid Eye Disease (TED)
WALTHAM, Mass.—Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company, announced that the Food and Drug Administration (FDA) has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease…
